13,14-dihydro-15-ketoprostaglandin D2

PGD2 metabolite; RN given refers to (5Z,9alpha)-isomer

Also Known As:

13,14-dihydro-15-keto-PGD2; 13,14-dihydro-15-keto-prostaglandin D2; Prost-5-en-1-oic acid, 9-hydroxy-11,15-dioxo-, (5Z,9alpha)-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Berry, Svanjita: 1 article (11/2019)
2.	Diwakar, Bastihalli T: 1 article (11/2019)
3.	Huffnagle, Ian: 1 article (11/2019)
4.	Lee, Tai-Jung: 1 article (11/2019)
5.	Nettleford, Shaneice: 1 article (11/2019)
6.	Paulson, Robert F: 1 article (11/2019)
7.	Prabhu, K Sandeep: 1 article (11/2019)
8.	Qian, Fenghua: 1 article (11/2019)
9.	Rossi, Randall M: 1 article (11/2019)
10.	Trebak, Mohamed: 1 article (11/2019)

1.	Inflammation (Inflammations) 03/15/2005 - "Furthermore, 13,14-dihydro-15-keto-PGD2, a specific DP2 agonist not only increases eosinophil recruitment at inflammatory sites but also the pathology in two in vivo models of allergic inflammation: atopic dermatitis and allergic asthma. " 11/01/2019 - "Ligand-dependent activation of Crth2 by 13,14-dihydro-15-keto-prostaglandin D2 increased Ca2+ influx through store-operated Ca2+ entry (SOCE) accompanied by the up-regulation of stromal interaction molecule 1 and calcium release-activated calcium modulator 1 expression, suggesting that the proresolution effects of CyPG-dependent activation of SOCE could be mediated by Crth2 during inflammation. "
2.	Atopic Dermatitis (Atopic Eczema) 03/15/2005 - "Furthermore, 13,14-dihydro-15-keto-PGD2, a specific DP2 agonist not only increases eosinophil recruitment at inflammatory sites but also the pathology in two in vivo models of allergic inflammation: atopic dermatitis and allergic asthma. "
3.	Asthma (Bronchial Asthma) 03/15/2005 - "Furthermore, 13,14-dihydro-15-keto-PGD2, a specific DP2 agonist not only increases eosinophil recruitment at inflammatory sites but also the pathology in two in vivo models of allergic inflammation: atopic dermatitis and allergic asthma. "

1.	Ligands
2.	Calcium
3.	Stromal Interaction Molecule 1